Stratec SE (ETR:SBS – Get Free Report) shares were up 1.1% on Monday . The stock traded as high as €19.58 and last traded at €19.50. Approximately 21,075 shares traded hands during mid-day trading, an increase of 237% from the average daily volume of 6,253 shares. The stock had previously closed at €19.28.
Stratec Stock Down 0.1%
The company’s fifty day simple moving average is €21.62 and its 200-day simple moving average is €23.88. The firm has a market capitalization of $229.46 million, a PE ratio of 22.92, a price-to-earnings-growth ratio of 10.43 and a beta of 0.72. The company has a debt-to-equity ratio of 55.08, a current ratio of 4.19 and a quick ratio of 1.65.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Read More
- Five stocks we like better than Stratec
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
